These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2358199)

  • 1. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
    Kobayashi T; Terao T; Kojima T; Takamatsu J; Kamiya T; Saito H
    Gynecol Obstet Invest; 1990; 29(3):235-8. PubMed ID: 2358199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
    Takahashi T; Hatao K; Suzukawa M; Oji T
    Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
    Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
    Asahina T; Kobayashi T; Takeuchi K; Kanayama N
    Obstet Gynecol Surv; 2007 Apr; 62(4):255-60. PubMed ID: 17371605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.
    Rodeghiero F; Castaman GC; Di Bona E; Ruggeri M; Dini E
    Blut; 1987 Jul; 55(1):45-8. PubMed ID: 3607295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
    Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
    Daly HM; Haddon ME
    Thromb Haemost; 1988 Apr; 59(2):171-4. PubMed ID: 3388293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Factor XIII concentrate in the long term management of congenital factor XIII deficiency.
    Miloszewski K; Losowsky MS
    Thromb Diath Haemorrh; 1975 Sep; 34(1):323-4. PubMed ID: 810913
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
    Abdel-Samad N
    Am J Case Rep; 2017 Apr; 18():436-439. PubMed ID: 28432284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].
    Egbring R; Andrassy K; Havemann K; Fuchs G; Ruf B; Schander K; Trobisch H
    Blut; 1976 Dec; 33(6):367-76. PubMed ID: 1000087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
    Tahlan A; Ahluwalia J
    Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.
    Burrows RF; Ray JG; Burrows EA
    Obstet Gynecol Surv; 2000 Feb; 55(2):103-8. PubMed ID: 10674253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
    Dargaud Y; de Mazancourt P; Rugeri L; Hanss M; Borg JY; Gaucherand P; Negrier C; Trzeciak C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):447-52. PubMed ID: 18600098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
    Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
    Nugent DJ
    Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tooth extraction in two patients who had a congenital deficiency of factor XIII.
    Suzuki H; Kaneda T
    J Oral Maxillofac Surg; 1985 Mar; 43(3):221-4. PubMed ID: 3156225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution of F XIII concentrate in ulcerative colitis].
    Lorenz R; Clemens R; Karl M; Classen M
    Z Gastroenterol; 1989 Feb; 27(2):87-90. PubMed ID: 2658393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate.
    Hanafusa N; Aozasa N; Fujita T
    Ther Apher Dial; 2010 Aug; 14(4):432-3. PubMed ID: 20649765
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
    Janbain M; Nugent DJ; Powell JS; St-Louis J; Frame VB; Leissinger CA
    Transfusion; 2015 Jan; 55(1):45-50. PubMed ID: 25070582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical course and management of severe congenital factor XIII deficiency].
    Meili EO
    Hamostaseologie; 2002 Feb; 22(1):48-52. PubMed ID: 12193985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.